{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:58:17Z","timestamp":1764046697718,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470516,81470402"],"award-info":[{"award-number":["81470516,81470402"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Technology Support Program of China","award":["2015BAI09B06"],"award-info":[{"award-number":["2015BAI09B06"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jphs.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T12:03:43Z","timestamp":1536062623000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Icariside II attenuates cardiac remodeling via AMPK\u03b12\/mTORC1 in\u00a0vivo and in\u00a0vitro"],"prefix":"10.1016","volume":"138","author":[{"given":"Xiao-Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-han","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2018.08.010_bib1","doi-asserted-by":"crossref","first-page":"3920195","DOI":"10.1155\/2017\/3920195","article-title":"A\u00a0review of the molecular mechanisms underlying the development and progression of cardiac remodeling","volume":"2017","author":"Schirone","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jphs.2018.08.010_bib2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1042\/CS20171167","article-title":"Mechanisms contributing to cardiac remodelling","volume":"131","author":"Wu","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jphs.2018.08.010_bib3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","article-title":"Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload","volume":"131","author":"Schiattarella","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2018.08.010_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jphs.2018.08.010_bib5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCRESAHA.117.309633","article-title":"AMP-activated protein kinase: an ubiquitous signaling pathway with key roles in the cardiovascular system","volume":"120","author":"Salt","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2018.08.010_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fphar.2017.00039","article-title":"Icariside II, a broad-spectrum anti-cancer agent, reverses beta-amyloid-induced cognitive impairment through reducing inflammation and apoptosis in rats","volume":"8","author":"Deng","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jphs.2018.08.010_bib7","first-page":"832","article-title":"Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes","volume":"33","author":"Zhou","year":"2012","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.jphs.2018.08.010_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuint.2017.10.015","article-title":"Icariside II, a PDE5 inhibitor from epimedium brevicornum, promotes neuron-like pheochromocytoma PC12 cell proliferation via activating NO\/cGMP\/PKG pathway","volume":"112","author":"Gao","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jphs.2018.08.010_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu8090563","article-title":"The anticancer properties of Herba Epimedii and its main bioactive components icariin and icariside II","volume":"8","author":"Chen","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.jphs.2018.08.010_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.biopha.2017.01.147","article-title":"Icariin prevents hypertension-induced cardiomyocyte apoptosis through the mitochondrial apoptotic pathway","volume":"88","author":"Qian","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2018.08.010_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biopha.2016.08.016","article-title":"Icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation","volume":"83","author":"Song","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2018.08.010_bib12","first-page":"4234","article-title":"Effect and mechanism of icariin on myocardial ischemia-reperfusion injury model in diabetes rats","volume":"40","author":"Hu","year":"2015","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.jphs.2018.08.010_bib13","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.3892\/mmr.2015.3289","article-title":"Icariin protects H9C2 cardiomyocytes from lipopolysaccharide induced injury via inhibition of the reactive oxygen species dependent c-Jun N-terminal kinases\/nuclear factor-\u03baB pathway","volume":"11","author":"Zhou","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jphs.2018.08.010_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-015-2520-1","article-title":"Oleanolic acid alleviated pressure overload-induced cardiac remodeling","volume":"409","author":"Liao","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jphs.2018.08.010_bib15","doi-asserted-by":"crossref","first-page":"8370593","DOI":"10.1155\/2017\/8370593","article-title":"Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting I\u03baB\/NF\u03baB and enhancing Nrf2\/HO-1","volume":"2017","author":"Liao","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jphs.2018.08.010_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00018-016-2407-7","article-title":"Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?","volume":"74","author":"Li","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jphs.2018.08.010_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2018.08.010_bib18","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","article-title":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction","volume":"284","author":"Ikeda","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2018.08.010_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cvr\/cvr034","article-title":"AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure","volume":"90","author":"Beauloye","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jphs.2018.08.010_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.113.02619","article-title":"Metformin protects against systolic overload-induced heart failure independent of AMPK-activated protein kinase a 2","volume":"63","author":"Xu","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jphs.2018.08.010_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCHEARTFAILURE.114.001677","article-title":"Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism","volume":"8","author":"Sung","year":"2015","journal-title":"Circulation. Heart failure."},{"key":"10.1016\/j.jphs.2018.08.010_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ajh\/hpu017","article-title":"Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1\/AMPK\/p70S6K signaling pathway","volume":"27","author":"Zhu","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jphs.2018.08.010_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1755-5922.12101","article-title":"Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the met-remodel study): rationale and design of the met-remodel study","volume":"33","author":"Mohan","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jphs.2018.08.010_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2015.04.008","article-title":"Lack of efficacy of resveratrol on c-reactive protein and selected cardiovascular risk factors--results from a systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Sahebkar","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jphs.2018.08.010_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","article-title":"AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation","volume":"91","author":"Daskalopoulos","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jphs.2018.08.010_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2015.01.007","article-title":"The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling","volume":"82","author":"Calamaras","year":"2015","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.jphs.2018.08.010_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/jcmm.12480","article-title":"Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats","volume":"19","author":"Wang","year":"2015","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jphs.2018.08.010_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7150\/ijbs.14213","article-title":"Asiatic acid protects against cardiac hypertrophy through activating AMPKa signalling pathway","volume":"12","author":"Ma","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jphs.2018.08.010_bib29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/bph.13449","article-title":"Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor\/AMPKa signalling pathway","volume":"173","author":"Ma","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2018.08.010_bib30","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/mnfr.201300012","article-title":"Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-a","volume":"57","author":"Deng","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jphs.2018.08.010_bib31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/andr.303","article-title":"Icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through akt-enos signaling pathway","volume":"3","author":"Li","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.jphs.2018.08.010_bib32","first-page":"2077","article-title":"Icariside II promotes the osteogenic differentiation of canine bone marrow mesenchymal stem cells via the PI3K\/Akt\/mTOR\/S6K signaling pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jphs.2018.08.010_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopha.2018.01.138","article-title":"Icariside II attenuates myocardial fibrosis by inhibiting nuclear factor-kappaB and the TGF-beta1\/Smad2 signalling pathway in spontaneously hypertensive rats","volume":"100","author":"Fu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2018.08.010_bib34","first-page":"4099","article-title":"Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt\/NOS\/NF-kappaB signaling","volume":"17","author":"Yang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jphs.2018.08.010_bib35","first-page":"500","article-title":"Effects of icariin and icariside II on eNOS expression and NOS activity in porcine aorta endothelial cells","volume":"43","author":"Liu","year":"2011","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jphs.2018.08.010_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.10.003","article-title":"PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer","volume":"147","author":"Das","year":"2015","journal-title":"Pharmacol Ther"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861318301658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861318301658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T08:46:38Z","timestamp":1540197998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861318301658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1347861318301658"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2018.08.010","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icariside II attenuates cardiac remodeling via AMPK\u03b12\/mTORC1 in\u00a0vivo and in\u00a0vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}